FKTN and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: To evaluate the ability of the new monoclonal antibodies to detect not only fully glycosylated αDG, but also the smaller abnormal isoform, Western blots were performed on solubilized mouse skeletal muscle lysates from normal littermates and Fktn-deficient dystroglycanopathy mice.